Aim: COVID-19 is an epidemic communicable disease that has been declared as a pandemic caused by severe acute respiratory syndrome coronavirus 2. Clinical studies have demonstrated that advanced age and comorbid conditions enhance the severity of the infection. The objective of this study was to examine the of effects of blood group types on risk of infection, disease severity, and mortality in COVID-19 patients. Material and Method: Included in this study were 1618 patients who had been diagnosed with PCR confirmed COVID-19 infection. The age, gender, blood type, disease severity, need for intensive care, and deaths of the patients were analyzed retrospectively. For the distribution of the blood types in a healthy population, statistics for the blood types of individuals in Ankara for 2020 were obtained from the Republic of Turkey Red Crescent Blood Services and used as a healthy control group for comparison with the data of the patients included in the study. Results: Among the COVID-19 patients, blood type A was the most common type at a rate of 46.2%. This was followed by blood type O at a rate of 28.4%. The least common blood type was found to be type AB at a rate of 9%. When compared to the healthy population, blood type A was determined to be statistically significantly more common in COVID-19 infection (p=0.07,). In contrast, blood type O was determined to be less common when compared to the healthy population (p
It is known that the use of inhaled corticosteroids increases the incidence of pneumonia in patients followed up with the diagnosis of chronic asthma and chronic obstructive pulmonary disease (COPD). This study aimed to investigate the contribution of inhaled steroid use to pneumonia severity and mortality in cases with COVID-19 pneumonia. The study is a retrospective, observational study. Among the cases admitted to the pandemic clinic, patients diagnosed with COVID-19 pneumonia were included. The plan was to compare cases who received and did not receive inhaled corticosteroids in terms of pneumonia severity and mortality. In order to define risk factors for mortality, univariate and multivariable negative binomial regression analyses were performed. In our study, it was observed that n= 540 (75%) cases did not receive inhaled corticosteroids (group 1), and 180 (25%) cases used inhaled corti costeroids (group 2). Group 1 and group 2 cases were compared in terms of pneumonia severity with no significant difference between the two groups (p= 0.11). Then, risk factors affecting mortality in all cases were examined with univariate analyses. Increasing age, applying mechanical ventilation, having severe pneumonia, having interstitial lung disease, and applying prone position were found to be statistically significant factors in mortality (p < 0.05). In conclusion, in our study, it was observed that the use of inhaled corticosteroids did not increase the severity of pneumonia and mortality. It was thought that the treatment they received could be continued when the patients treated with inhaled corticosteroids due to asthma and COPD had COVID-19 pneumonia.
30 July 2025 in Journal of Health Sciences and Medicine
Aims: Primary hyperparathyroidism (PHPT), a well-recognized endocrine disorder, is subclassified into hypercalcemic and normocalcemic forms. Recent studies suggest that biochemical ratios such as the chloride-to-phosphorus (Cl/P) and chloride-to-magnesium (Cl/Mg) ratios may aid in the diagnostic evaluation and risk stratification of PHPT-related complications. This study aimed to investigate the diagnostic and predictive utility of the Cl/P and Cl/Mg ratios in differentiating PHPT subtypes and assessing the risk of osteoporosis and nephrolithiasis. Methods: This retrospective study included 116 patients who underwent parathyroidectomy for PHPT at Ankara Bilkent City Hospital between 2019 and 2022. All patients met surgical criteria based on international guidelines, and normocalcemic PHPT (N-PHPT) cases were defined by repeatedly normal calcium measurements and exclusion of secondary causes. Preoperative biochemical parameters, imaging findings, and complication profiles were analyzed. Cl/P and Cl/Mg ratios were calculated and evaluated using the Mann-Whitney U test, Spearman correlation, and receiver operating characteristic (ROC) analysis. Results: The Cl/P ratio was significantly higher in hypercalcemic PHPT than in normocalcemic patients (median 42.4 vs. 38.3, p=0.0125) and was positively associated with bone mineral density. A Cl/P threshold of >43.6 yielded 80.0% specificity in distinguishing PHPT subtypes [area under the curve (AUC): 64.1%]. The Cl/Mg ratio, although not differing between subtypes, was significantly associated with nephrolithiasis risk, with a cut-off value of ≤55 providing 82.4% sensitivity and 66.7% specificity (AUC: 70.5%, p